10x Genomics is trading at $71.01, down 6.69%, amid broader market pressure consistent with higher oil prices and Treasury yields.
- No clear company-specific announcement or catalyst was found for the October 8 decline.
- Reuters reported October 8 U.S. futures fell as inflation concerns grew; the 10-year Treasury yield was 5.34% and Brent crude topped $105.
- Sharp declines on October 6 and 7 preceded this move, indicating an ongoing pullback, not evidence of a new company event.